Krystal Biotech, Inc.
Krystal Biotech, Inc. (KRYS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
krys · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$371
Consensus
$326
+8.1% upside
Low
$300
Median: $323 · Last Close: $301.76
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$326.20
8.1% upside
High Target
$371
22.9%
Low Target
$300
-0.6%
Current Price
$301.76
as of today
Based on analyst price targets, the KRYS stock price prediction for the next 12 months ranges from $300 to $371. The consensus KRYS price forecast of $326.20 implies 8.1% upside from the current price of $301.76.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $298.84 | ↓ 0.97% |
1-day model range: $297.45–$300.22. Peak: $300.22 (-0.97%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $478 | +58.3% |
| 2028 | $645 | +113.7% |
| 2029 | $780 | +158.5% |
| 2030 | $878 | +191.1% |
| 2031 | — | +213.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KRYS · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-05 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-05 | Citigroup | Maintains | Buy→Buy |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Guggenheim | Maintains | Buy→Buy |
| 2026-02-18 | Chardan Capital | Maintains | Buy→Buy |
| 2026-02-18 | Citigroup | Maintains | Buy→Buy |
| 2026-02-17 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Krystal Biotech, Inc. (KRYS) stock. Of the recent 115 rating actions, 3 were upgrades and 2 were downgrades. 17 analysts currently cover KRYS.
Analyst Recommendation Trends
KRYS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$522M
↓ 38.4% YoY
Revenue Next Year
$660M
↑ 26.3% YoY
EPS This Year
$7.75
EPS Next Year
$9.71
↑ 25.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast KRYS EPS of $7.75 for the current fiscal year, based on estimates from 8 analysts. The KRYS revenue forecast is $522M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The KRYS stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus KRYS price target is $326.20 (+8.1% upside), with an analyst consensus of Buy.
The KRYS short-term stock prediction for tomorrow is $298.84 (-0.97%). The KRYS stock price prediction for 2027 estimates an average of $478. The KRYS stock prediction for 2030 projects a range of $834–$923.
Krystal Biotech, Inc. trades on NASDAQ under the ticker KRYS. The KRYS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
KRYS forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month KRYS price target is $326.20, with a high forecast of $371.00 and a low of $300.00. The median price target is shown in the chart above when available. This implies +8.1% potential upside from the current price of $301.76.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.